XM does not provide services to residents of the United States of America.
C
C

CaraTherapeutics

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Cara Therapeutics Announces Exploration Of Strategic Alternatives

BRIEF-Cara Therapeutics Announces Exploration Of Strategic Alternatives July 11 (Reuters) - Cara Therapeutics Inc CARA.O : CARA THERAPEUTICS ANNOUNCES EXPLORATION OF STRATEGIC ALTERNATIVES CARA THERAPEUTICS INC - ENGAGES PIPER SANDLER AS FINANCIAL ADVISOR Source text for Eikon: ID:nGNX3pYKNW Further company coverage: CARA.O
C

Cara Therapeutics Says Board Approved A Streamlined Operating Plan Exploring Strategic Alternatives Focused On Maximizing Shareholder Value

BRIEF-Cara Therapeutics Says Board Approved A Streamlined Operating Plan Exploring Strategic Alternatives Focused On Maximizing Shareholder Value June 18 (Reuters) - Cara Therapeutics Inc CARA.O : CARA THERAPEUTICS - ON JUNE 14 BOARD APPROVED A STREAMLINED OPERATING PLAN EXPLORING STRATEGIC ALTERNATIVES FOCUSED ON MAXIMIZING SHAREHOLDER VALUE CARA
C

U.S. STOCKS ACI Worldwide, enCore Energy, Adobe

BUZZ-U.S. STOCKS ON THE MOVE-ACI Worldwide, enCore Energy, Adobe Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Dow indexes slipped on Thursday as investors weighed hawkish Federal Reserve projections against data signaling cooling inflation, though strength in chip stocks supported the Nasdaq.
A
B
B
C
P
T
S
U
U
G
V
W
A

U.S. STOCKS Williams-Sonoma, ACI Worldwide, enCore Energy

BUZZ-U.S. STOCKS ON THE MOVE-Williams-Sonoma, ACI Worldwide, enCore Energy Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and Nasdaq indexes hovered near record highs on Thursday, boosted by a jump in chip stocks after lower-than-forecast producer inflation data fanned expectations of interest-rate cuts from the Federal Reserve.
B
B
C
P
T
S
U
U
G
V
W
A

U.S. STOCKS Vivani, Vanda, Sarepta

BUZZ-U.S. STOCKS ON THE MOVE-Vivani, Vanda, Sarepta Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Futures tracking the Nasdaq leapt on Thursday on gains in heavyweighttechnology stocks, aided by broadly unchanged bets on the Federal Reserve easing interest rates in September despite the central bank projecting just one cut this year.
B
B
C
P
T
U
V

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.